[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 31 31 97 53", "website": "https://evaxion.ai", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 47, "title": "Interim CEO & Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 343000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 48, "title": "Founder & Chief AI Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 326000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Frederik Schmidt M.Sc.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 77000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.6, "open": 9.3, "dayLow": 6.25, "dayHigh": 9.4999, "regularMarketPreviousClose": 9.6, "regularMarketOpen": 9.3, "regularMarketDayLow": 6.25, "regularMarketDayHigh": 9.4999, "payoutRatio": 0.0, "beta": 0.234, "forwardPE": -5.388889, "volume": 1939084, "regularMarketVolume": 1939084, "averageVolume": 1557703, "averageVolume10days": 1231280, "averageDailyVolume10Day": 1231280, "bid": 5.35, "ask": 7.84, "bidSize": 2, "askSize": 2, "marketCap": 42889524, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 15.5, "allTimeHigh": 1252.0, "allTimeLow": 1.2, "priceToSalesTrailing12Months": 13.504258, "fiftyDayAverage": 4.02196, "twoHundredDayAverage": 2.81587, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2141013248, "profitMargins": 0.0, "floatShares": 177287226, "sharesOutstanding": 6316572, "sharesShort": 636918, "sharesShortPriorMonth": 120344, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1008, "heldPercentInsiders": 0.23066, "heldPercentInstitutions": 0.068179995, "shortRatio": 0.16, "shortPercentOfFloat": 0.1338, "impliedSharesOutstanding": 6316570, "bookValue": 0.986, "priceToBook": 6.8864098, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11974000, "trailingEps": -6.5, "forwardEps": -1.26, "lastSplitFactor": "1:5", "lastSplitDate": 1736812800, "enterpriseToRevenue": 674.123, "enterpriseToEbitda": -157.214, "52WeekChange": -0.46535432, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 6.79, "targetHighPrice": 19.75, "targetLowPrice": 11.0, "targetMeanPrice": 15.58333, "targetMedianPrice": 16.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 14746000, "totalCashPerShare": 0.047, "ebitda": -13618500, "totalDebt": 11283000, "quickRatio": 2.933, "currentRatio": 3.415, "totalRevenue": 3176000, "debtToEquity": 181.224, "revenuePerShare": 1.179, "returnOnAssets": -0.46321, "returnOnEquity": -3.20203, "grossProfits": 3176000, "freeCashflow": -7957000, "operatingCashflow": -11679000, "revenueGrowth": -0.76, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -117.2973, "financialCurrency": "USD", "symbol": "EVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Evaxion A/S", "longName": "Evaxion A/S", "postMarketChangePercent": 5.7408, "postMarketPrice": 7.1798, "postMarketChange": 0.3898, "regularMarketChange": -2.81, "regularMarketDayRange": "6.25 - 9.4999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1557703, "fiftyTwoWeekLowChange": 5.59, "fiftyTwoWeekLowChangePercent": 4.6583333, "fiftyTwoWeekRange": "1.2 - 15.5", "fiftyTwoWeekHighChange": -8.71, "fiftyTwoWeekHighChangePercent": -0.5619355, "fiftyTwoWeekChangePercent": -46.53543, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "corporateActions": [], "postMarketTime": 1760745587, "regularMarketTime": 1760731201, "exchange": "NCM", "messageBoardId": "finmb_319014926", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsCallTimestampStart": 1748349000, "earningsCallTimestampEnd": 1748349000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.5, "epsForward": -1.26, "epsCurrentYear": -0.03, "priceEpsCurrentYear": -226.33334, "fiftyDayAverageChange": 2.7680402, "fiftyDayAverageChangePercent": 0.6882317, "twoHundredDayAverageChange": 3.97413, "twoHundredDayAverageChangePercent": 1.4113328, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Evaxion Biotech A/S", "nameChangeDate": "2025-10-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -29.2708, "regularMarketPrice": 6.79, "marketState": "CLOSED", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]